Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.

Ochi A, Ishimura E, Ichii M, Ohno Y, Nakatani S, Kobayashi I, Shima H, Tsuda A, Shidara K, Mori K, Tamori A, Inaba M.

Nephrology (Carlton). 2014 Sep;19(9):595-6. doi: 10.1111/nep.12292. No abstract available.

PMID:
25156438
[PubMed - in process]
2.

Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.

Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

J Clin Endocrinol Metab. 2014 Aug 5:jc20142372. [Epub ahead of print]

PMID:
25093620
[PubMed - as supplied by publisher]
3.

Effect of corticosteroid therapy on renal pathology in IgG4-related kidney disease accompanying glomerulonephritis.

Nakatani S, Ishimura E, Sonoda M, Ichii M, Ochi A, Tsuda A, Kobayashi I, Mori K, Osawa M, Inaba M.

Nephrology (Carlton). 2014 Jul;19(7):436-7. doi: 10.1111/nep.12259. No abstract available.

PMID:
24931114
[PubMed - in process]
4.

Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.

Nakatani S, Ishimura E, Naganuma T, Nakatani A, Ichii M, Fukumoto S, Mori K, Emoto M, Nakatani T, Inaba M.

Diabetes Res Clin Pract. 2014 Jul;105(1):40-6. doi: 10.1016/j.diabres.2014.04.019. Epub 2014 Apr 28.

PMID:
24846444
[PubMed - in process]
5.

Quantitative analysis of abdominal aortic calcification in CKD patients without dialysis therapy by use of the Agatston score.

Ichii M, Ishimura E, Shima H, Ohno Y, Ochi A, Nakatani S, Tsuda A, Ehara S, Mori K, Fukumoto S, Naganuma T, Takemoto Y, Nakatani T, Inaba M.

Kidney Blood Press Res. 2013;38(2-3):196-204. doi: 10.1159/000355768. Epub 2014 Apr 8.

PMID:
24732137
[PubMed - in process]
6.

Response to comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603.

Tsuda A, Ishimura E, Inaba M.

Diabetes Care. 2014 Apr;37(4):e84. doi: 10.2337/dc13-2869. No abstract available.

PMID:
24652743
[PubMed - in process]
7.

Significant association of poor glycemic control with increased resistance in efferent arterioles--study of inulin and para-aminohippuric acid clearance in humans.

Tsuda A, Ishimura E, Ohno Y, Ichii M, Nakatani S, Mori K, Fukumoto S, Emoto M, Inaba M.

Diabetes Res Clin Pract. 2014 May;104(2):234-40. doi: 10.1016/j.diabres.2014.01.030. Epub 2014 Feb 11.

PMID:
24598266
[PubMed - in process]
8.

Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.

Ochi A, Mori K, Emoto M, Nakatani S, Morioka T, Motoyama K, Fukumoto S, Imanishi Y, Koyama H, Ishimura E, Inaba M.

PLoS One. 2014 Feb 13;9(2):e88704. doi: 10.1371/journal.pone.0088704. eCollection 2014.

PMID:
24551137
[PubMed - in process]
Free PMC Article
9.

Significant positive relationship between serum magnesium and muscle quality in maintenance hemodialysis patients.

Okazaki H, Ishimura E, Okuno S, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

Magnes Res. 2013 Oct-Dec;26(4):182-7. doi: 10.1684/mrh.2014.0352.

PMID:
24491526
[PubMed - in process]
10.

Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients.

Tsuda A, Ishimura E, Ohno Y, Ichii M, Nakatani S, Machida Y, Mori K, Uchida J, Fukumoto S, Emoto M, Nakatani T, Inaba M.

Diabetes Care. 2014 Mar;37(3):596-603. doi: 10.2337/dc13-1899. Epub 2013 Oct 15.

PMID:
24130341
[PubMed - in process]
11.

Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.

Inaba M, Okuno S, Imanishi Y, Ishimura E, Yamakawa T, Shoji S.

Osteoporos Int. 2013 Nov;24(11):2863-70. doi: 10.1007/s00198-012-2245-x. Epub 2013 Sep 13.

PMID:
24030285
[PubMed - indexed for MEDLINE]
12.

Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients.

Ochi A, Ishimura E, Tsujimoto Y, Kakiya R, Tabata T, Mori K, Fukumoto S, Tahara H, Shoji T, Yasuda H, Nishizawa Y, Inaba M.

Circ J. 2013;77(12):3029-36. Epub 2013 Aug 23.

PMID:
23979658
[PubMed - indexed for MEDLINE]
Free Article
13.

[Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis].

Nanno S, Nakamae H, Kuwamura Y, Ishimura E, Sakabe M, Inaba A, Koh S, Yoshimura T, Nishimoto M, Hayashi Y, Terada Y, Nakane T, Koh H, Nakao Y, Ohsawa M, Hino M.

Rinsho Ketsueki. 2013 Jul;54(7):658-63. Review. Japanese.

PMID:
23912350
[PubMed - indexed for MEDLINE]
14.

Cerebral white matter hyperintensity predicts cardiovascular events in haemodialysis patients.

Naganuma T, Takemoto Y, Shoji T, Shima H, Ishimura E, Okamura M, Nakatani T.

Nephrology (Carlton). 2013 Oct;18(10):676-81. doi: 10.1111/nep.12115.

PMID:
23782310
[PubMed - indexed for MEDLINE]
15.

Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.

Nakatani S, Ishimura E, Mori K, Fukumoto S, Yamano S, Wei M, Emoto M, Wanibuchi H, Inaba M.

Nephron Clin Pract. 2012;122(3-4):114-21. doi: 10.1159/000350816. Epub 2013 May 8.

PMID:
23689482
[PubMed - indexed for MEDLINE]
16.

Relationship between serum TSH levels and intrarenal hemodynamic parameters in euthyroid subjects.

Tsuda A, Inaba M, Ichii M, Ochi A, Ohno Y, Nakatani S, Yamada S, Mori K, Tahara H, Ishimura E.

Eur J Endocrinol. 2013 Jun 1;169(1):45-50. doi: 10.1530/EJE-13-0026. Print 2013 Jul.

PMID:
23585555
[PubMed - indexed for MEDLINE]
Free Article
17.

Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto's thyroiditis.

Wakita Y, Nagasaki T, Nagata Y, Imanishi Y, Yamada S, Yoda K, Emoto M, Ishimura E, Inaba M.

Thyroid Res. 2013 Mar 23;6(1):5. doi: 10.1186/1756-6614-6-5.

PMID:
23522401
[PubMed]
Free PMC Article
18.

Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients.

Ishimura E, Okuno S, Tsuboniwa N, Norimine K, Fukumoto S, Yamakawa K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

J Clin Endocrinol Metab. 2013 Mar;98(3):1264-70. doi: 10.1210/jc.2012-3883. Epub 2013 Feb 7.

PMID:
23393179
[PubMed - indexed for MEDLINE]
19.

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.

Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology.

Clin Exp Nephrol. 2013 Apr;17(2):155-73. doi: 10.1007/s10157-012-0746-8. Epub 2013 Feb 6.

PMID:
23385776
[PubMed - indexed for MEDLINE]
20.

Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.

Mori K, Okuno S, Shoji T, Emoto M, Kakutani Y, Yamakawa K, Imanishi Y, Ishimura E, Yamakawa T, Shoji S, Inaba M.

Cytokine. 2013 Mar;61(3):912-6. doi: 10.1016/j.cyto.2012.12.030. Epub 2013 Feb 4.

PMID:
23384657
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk